Frequent Dosing Regimen of Lucentis for Subjects With Persistent Diabetic Macular Edema Despite Standard antiVEGF Dosing
Status:
Withdrawn
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
The investigators would like to investigate the efficacy of more frequent treatment with
Lucentis for subjects with persistent diabetic macular edema despite standard dosing regimen.